The Reversion of the Epigenetic Signature of Coronary Heart Disease in Response to Smoking Cessation is a research paper published in Genes (2023). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Eric Hoffman, PI
Grant: 5R01HL130883
Eric Hoffman, PI
Grant: S10OD026960
Eric Hoffman, PI
Grant: R44CA213507
NHLBI NIH HHS
Grant: R01 HL130883
NIEHS NIH HHS
Grant: P30 ES005605
National Institutes of Health
Grant: 1S10OD026960-01
Hyperpolarized Xe-129 MRI for Functional Lung Phenotyping
National Institutes of Health
Grant: 5R44CA213507-02
A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy
National Institutes of Health
Grant: 5R01HL130883-02
Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema
Cardio Diagnostics Inc.
FWCI
0.74
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals